Neo Soma Healthcare review

Neo Soma identifies its Texas service area, medical director and pharmacy, and publishes introductory and refill prices. Compare the periods carefully: semaglutide’s $99 offer covers six weeks, while subsequent dose tiers are priced every four weeks. The sermorelin and NAD⁺ pages display two prices without clearly assigning each to an initial or renewal charge.

Neo Soma Healthcare is a Leander, Texas telehealth storefront offering compounded weight-management medication, sermorelin and NAD⁺. Its About page names Stephen Bunker, MD as chief medical director; the FAQ names Strive Pharmacy in San Antonio and says providers currently serve Texas only. The medication FAQ says clinicians may prescribe semaglutide, tirzepatide or liraglutide when appropriate, while the current purchasable weight-management catalog shows semaglutide and tirzepatide. This does not establish brand-name dispensing.

Patients select a treatment and complete an online intake for clinical review, with follow-up messaging available. The FAQ identifies Strive Pharmacy at 1077 Central Parkway S, Suite 800, San Antonio, Texas, and limits service to Texas. It describes semaglutide FedEx Express dispatch on Mondays and Wednesdays, with one to two days after shipment; tirzepatide pharmacy preparation is described as three to five business days. Those are different stages, not guaranteed order-to-door times. General terms authorize recurring charges until cancellation and describe sales as final. The separate refund page has a heading but no published policy body, so confirm any treatment-specific cancellation deadline.

Semaglutide is advertised at $99 for an initial six-week supply. The FAQ prices subsequent four-week refills at $199 for its 0.25–1 mg/week tier and $299 for its 1.5–2.4 mg/week tier. These are seller billing tiers, not instructions to select or change a dose. Tirzepatide’s product page shows a $330 initial six-week one-time purchase, with $495 also displayed; the FAQ says refills start at $495 every four weeks at the lowest dose. Confirm the chosen prescription’s first supply and refill charge.

Sermorelin displays $229 and $179, and NAD⁺ $219 and $175, with monthly-refill labels. The public pages do not clearly assign the paired amounts to a first versus renewal debit. Do not treat the lower number as a verified recurring four-week charge. General terms describe sales as final and recurring billing until canceled; a separate refund-policy body is not published. Ask for the full selected charge, supply, future billing period and cancellation deadline.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Neo Soma publishes the disclaimer plainly — compounded medications prescribed by its providers are not FDA-approved — and names Strive Pharmacy as its compounder, though compounded preparations are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, sermorelin is a growth-hormone-releasing hormone analog that stimulates your own pituitary rather than supplying growth hormone. That mechanism is real and well described; what stays thin is long-term human outcome data for the body-composition, sleep and recovery benefits it is sold for. Injected NAD⁺ is weaker still: there are no controlled human outcome trials for injected, intranasal or sublingual NAD⁺, and the single human intravenous study was a pharmacokinetic pilot. The NAD⁺ forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker, not a demonstrated clinical benefit. Individual results vary.